期刊文献+

脂质体携载前列腺素E_1含血停搏液对未成熟心肌的保护效果 被引量:1

Protective effects of Lipo-PGE_1 blood cardioplegia on immature myocardium
下载PDF
导出
摘要 目的:探讨脂质体携载前列腺素E1(Lipo -PGE1)加入ThomasⅡ停搏液对未成熟心肌的保护效果。方法:2~3周龄新西兰大白兔2 0只,随机分为2组,每组10只。建立Langendoff离体心脏灌注模型。对照组:ThomasⅡ号停搏液灌注加低温;实验组:Lipo -PGE1加入ThomasⅡ号停搏液灌注并行低温。全心平均停循环90min ,再灌注30min。观察指标:冠脉流量恢复率(CFR)、心肌丙二醛(MDA) /超氧化物岐化酶(SOD)含量、心肌三磷酸腺苷ATP含量、心肌含水量、心肌磷酸肌酸激酶(CK)漏出量和乳酸脱氢酶(LDH)漏出量。结果:再灌注末实验组心肌MDA含量低于对照组,而SOD含量高于对照组;实验组CFR和再灌注末心肌ATP含量高于对照组;实验组心肌含水量、CK和LDH漏出量低于对照组。结论:Lipo -PGE1加入含血ThomasⅡ号停搏液可改善对未成熟心肌的保护效果。 Objective:To study the protective effect of Lipo-PGE 1 blood cardioplegic solution to immature rabbit heart. Methods:the isolated, Langendoff of perfused rabbit's hearts were used. Twenty rabbits (2-3weeks) were randomly divided into two groups receiving topical cooling alone (15-17C), St. Thomas blood cardioplegic solution plus topical cooling and Lipo-PGE 1 blood cardioplegic solution plus topical reperfusion. The coronary sinus flow recovery (CFR), the myocardial water content(MWC), the myocardial ultrastructure, lactate dehydrogenase (LDH) creatine kinase (CK) leakage, adenosine triphosphate (ATP), the myocardial melodiadehyde (MDA), and myocardial superoxide dismutase(SOD) were measured. Results:The SOD activity increased and the MDA content decreased in studying group as compared with control groups. The CFR and the ATP content in studying group were higher than those of control group. The MWC, the LDH, and the CK Leakage in studying group were lower than those of control group. Conclusion: As a valuable addition to hypothermic cardioplegia, Lipo-PGE 1 produces better protection of the myocardium in immature rabbit heart.
出处 《赣南医学院学报》 2005年第2期143-145,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 脂质体携载前列腺素E1 未成熟心肌 停搏液 Lipo-PGE 1 immature myocardium myocardial protection cardioplegia
  • 相关文献

参考文献9

  • 1金铭.病理生理学(第五版)[M].北京:人民卫生出版社,2001.150-162. 被引量:1
  • 2Pacher R, Stanek B. Prostaglandin E1 in heart failure:The Vienna experience[J]. Wien Klin Wochenschr,1996, 108(16): 491-497. 被引量:1
  • 3Toyota T, Hirata Y, Ikeda Y, et al. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1:Placebo and prostaglandin E1 controlled multicenter trials in patients with diabetic neuropathy and leg ulcers[J].Prostaglandin, 1993, 46(5):453-456. 被引量:1
  • 4Long W A, Rubin L J. Prostaglandin E1 treatment of pulmonary hypertension[J]. Am Rev Respir Dis, 1987,136(3):773-776. 被引量:1
  • 5Mangiafico R A, Malatino L S, Santonocito M, et al.Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication[J]. Int J Clin Pharmacol Ther, 1999,37(7): 347-351. 被引量:1
  • 6Davidson S M, Cabral L D, Maurio F P, et al. Association and release of PGE1 from liposomes[J]. Biochem Biophys Acta, 1997,1327(1):97- 106. 被引量:1
  • 7Feld S, LiG, Wu A, et al. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: Comparison with control, placebo liposomes, and continous intravenous infusion of prostaglandin E1[J]. Am Heart J, 1996, 132(4): 747-757. 被引量:1
  • 8Smalling R, Uthman M, Ramanna N, et al. Suppression of ICAML and P-election adhesion molecule expression by bolus iv liposomal PGE1 (TLC C-53) immediately prior to reperfusion in a two hour canine infarct/reperfusion model (abstract)[J]. J Am Coll Cardiol,1995,25:248A. 被引量:1
  • 9冯国清,刘洁,傅润芳,翁世艾.前列腺素E_1对大鼠心肌缺血再灌注损伤的保护作用[J].河南医学研究,1997,6(3):216-218. 被引量:23

二级参考文献2

共引文献22

同被引文献15

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部